Neuroblastoma News and Research

RSS
Crucial change in single DNA base predisposes children to aggressive form of cancer

Crucial change in single DNA base predisposes children to aggressive form of cancer

Environmental factors may lead to development of some childhood cancers

Environmental factors may lead to development of some childhood cancers

International research project examines effectiveness of tried and tested medicines for different diseases

International research project examines effectiveness of tried and tested medicines for different diseases

Cancer-causing gene disrupts internal rhythm, metabolic pathways in cancer cells

Cancer-causing gene disrupts internal rhythm, metabolic pathways in cancer cells

CHAM, AECC receive $1.3 million NCI grant to advance more effective bone cancer treatments for children

CHAM, AECC receive $1.3 million NCI grant to advance more effective bone cancer treatments for children

AbbVie’s subsidiary to acquire United Therapeutics’ Rare Pediatric Disease Priority Review Voucher

AbbVie’s subsidiary to acquire United Therapeutics’ Rare Pediatric Disease Priority Review Voucher

Unituxin (dinutuximab) granted EC Marketing Authorisation for treatment of childhood neuroblastoma

Unituxin (dinutuximab) granted EC Marketing Authorisation for treatment of childhood neuroblastoma

Childhood cancer cells produce molecule that affects body's immune system to fight disease

Childhood cancer cells produce molecule that affects body's immune system to fight disease

UofL conducts Phase I research study for children with relapsed tumors

UofL conducts Phase I research study for children with relapsed tumors

Novogen's Anisina granted FDA Orphan Drug Designation for neuroblastoma

Novogen's Anisina granted FDA Orphan Drug Designation for neuroblastoma

Study shows that Anisina has potential to improve effectiveness of chemotherapy in children with cancer

Study shows that Anisina has potential to improve effectiveness of chemotherapy in children with cancer

Researchers complete phase 1 clinical trial of new drug for children suffering from neuroblastoma

Researchers complete phase 1 clinical trial of new drug for children suffering from neuroblastoma

Study may lead to better treatments for children with neuroblastoma

Study may lead to better treatments for children with neuroblastoma

Novogen’s chemotherapy drug Anisina proves as effective anti-cancer agent in animals

Novogen’s chemotherapy drug Anisina proves as effective anti-cancer agent in animals

Dell extends partnership with TGen to globally expand precision medicine trial for pediatric cancer

Dell extends partnership with TGen to globally expand precision medicine trial for pediatric cancer

Fennec presents positive interim results from phase III trial of sodium thiosulphate at ASCO 2015

Fennec presents positive interim results from phase III trial of sodium thiosulphate at ASCO 2015

Johns Hopkins scientists safely use immune cells to treat multiple myeloma

Johns Hopkins scientists safely use immune cells to treat multiple myeloma

Researchers make major step toward finding target to combat drug-resistant neuroblastoma

Researchers make major step toward finding target to combat drug-resistant neuroblastoma

UM cell biologist advances research about behavior of cell proteins in neuroblastoma

UM cell biologist advances research about behavior of cell proteins in neuroblastoma

UQDI reveals that Anisina drug can kill melanoma cells

UQDI reveals that Anisina drug can kill melanoma cells